Preparation, characterization and evaluation of targeting potential of amphotericin b-loaded engineered PLGA nanoparticles

Pharmaceutical Research

Volumn 26, Issue 12, 2009, Pages 2588-2598

  Nahar, Manoj ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Amphotericin B; J774A.1 Cell; Macrophages; Nanoparticles; Spacer

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; MANNOSE; NANOCARRIER; POLYGLACTIN;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TARGETING; DRUG UPTAKE; LECTIN BINDING; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; LACTIC ACID; LEISHMANIA DONOVANI; MACROPHAGES; MANNOSE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

EID: 70449123609     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9973-4     Document Type: Article

References (32)

1. M Nahar D Mishra V Dubey NK Jain 2008 Development, characterization and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles Nanomed Nanotech Bio Med. 4 252 61 10.1016/j.nano.2008.03.007
2. Y Matsumura H Maeda 1986 A new concept for macromolecular therapeutics in cancer chemotherapy Cancer Res. 46 6387 92 1:CAS:528:DyaL2sXnvVensA%3D%3D 2946403
3. M Owais CM Gupta 2005 Targeted drug delivery to macrophages in parasitic infections Cur Drug Del. 2 4 311 8 10.2174/156720105774370177 1:CAS:528:DC%2BD2MXhtVSkt7%2FJ (Pubitemid 41277764)
4. F Chellat Y Merhi A Moreau LH Yahia 2005 Therapeutic potential of nanoparticulate systems for macrophage targeting Biomaterial 26 7260 75 10.1016/j.biomaterials.2005.05.044 1:CAS:528:DC%2BD2MXot1Wktr8%3D (Pubitemid 41133578)
5. M Nahar T Dutta S Murugesan A Asthana D Mishra S Saraf M Tare NK Jain 2006 Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives Crit Rev Ther Drug Carrier Syst. 23 259 318 1:CAS:528:DC%2BD2sXjs1Gmsr4%3D 17341200
6. A Sharma S Sharma GK Khuller 2004 Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis J Antimicrob Chemother. 54 4 761 6 10.1093/jac/dkh411 1:CAS:528:DC%2BD2cXotVyqsbo%3D 15329364 (Pubitemid 39386728)
7. R Kassab H Parrot-Lopez H Fessi J Menaucourt R Bonaly J Coulon 2002 Molecular recognition by kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres Bio Org Med Chem. 10 1767 75 10.1016/S0968-0896(02)00028-7 1:CAS:528:DC%2BD38XisFWhtLs%3D (Pubitemid 34286369)
8. J Olivier R Huertas HJ Lee F Calon WM Pardrige 2002 Synthesis of Pegylated immunonanoparticles Pharm Res. 19 8 1137 43 10.1023/A:1019842024814 1:CAS:528:DC%2BD38XmtlGgsr0%3D 12240939 (Pubitemid 34984997)
9. R Sett K Sarkar PK Das 1993 Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease J Infect Dis. 168 4 994 9 1:CAS:528:DyaK2cXhsFejuro%3D 8376846
10. F Ahsan IP Rivas MA Khan SA Torres 2002 Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages J Contr Rel. 79 1-3 29 40 10.1016/S0168-3659(01)00549-1 1:CAS:528:DC%2BD38XhtlSls7w%3D (Pubitemid 34164159)
11. MK Basu S Lala 2004 Macrophage specific drug delivery in experimental leishmaniasis Curr Mol Med. 4 6 681 9 10.2174/1566524043360186 1:CAS:528:DC%2BD2cXmvVKmt70%3D 15357216 (Pubitemid 39172370)
12. A Mukhopadhyay SK Basu 2003 Intracellular delivery of drugs to macrophages Adv Biocheml Eng /Biotech. 84 183 209 1:CAS:528:DC%2BD3sXptFChsrk%3D
13. P Chakraborty AN Bhaduri PK Das 1990 Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasis Biochem Biophy Res Comm. 166 404 11 10.1016/0006-291X(90)91959-V 1:CAS:528:DyaK3cXptFaqtQ%3D%3D (Pubitemid 20040200)
14. C Yamashita S Sone T Ogura H Kiwada 1991 Potential value of cetylmannoside-modified liposomes as carriers of macrophages activators to human blood monocytes Japan J Cancer Res. 82 569 75 1:CAS:528:DyaK3MXkvF2ju70%3D
15. CD Muller F Schuber 1989 Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages Biochem Biophy Acta 986 97 101 10.1016/0005-2736(89)90277-0 1:CAS:528: DyaK3cXosVSmsQ%3D%3D (Pubitemid 19281628)
16. GM Barratt D Nolibe A Yapo JF Petit JP Tenu 1987 Use of mannosylated liposomes for in vivo targeting of a macrophages activator and control of artificial pulmonary metastases Ann Instit Past Imm. 138 437 43 10.1016/S0769-2625(87)80054-5 1:STN:280:DyaL1c%2FgtVWntg%3D%3D
17. N Garcon G Gregoriadis M Taylor J Summerfield 1988 Mannose-mediated targeted immunoadjuvant action of liposomes Immunology 64 743 9 1:CAS:528:DyaL1cXlsFKjsb8%3D 3169846
18. K Akamatsu M Nisshikawa Y Takakura M Hashida 1977 Synthesis and biodistribution study of liver-specific prostaglandin E1 polymeric conjugate Int J Pharm. 155 65 10.1016/S0378-5173(97)00159-2 77
19. JP Mitchell DR Roberts J Langley F Koentgen JN Lambert 1999 A direct method for the formation of peptide and carbohydrate dendrimers Bio Org Med Chem Lett. 9 2785 8 10.1016/S0960-894X(99)00480-1 1:CAS:528:DyaK1MXms1ags78%3D (Pubitemid 29481162)
20. M Venier-Julienne J Benoit 1996 Preparation, purification and morphology of polymeric nanoparticles as drug carriers Pharm Acta Helv. 71 121 8 10.1016/0031-6865(95)00059-3 8810578 (Pubitemid 26281321)
21. I Echevarria C Barturen MJ Renedo MC Dios-Vieitez 1998 High-performance liquid chromatographic determination of amphotericin B in plasma and tissue; application to pharmacokinetic and tissue distribution studies in rats J Chromat A 819 171 6 10.1016/S0021-9673(98)00425-7 1:CAS:528:DyaK1cXmsFCntbs%3D (Pubitemid 28401401)
22. U Westedt M Kalinowski Wittmar Ms T Merdan F Unger J Fuchs S Schäller U Bakowsky T Kissel 2007 Poly(vinyl alcohol)-graft-poly(lactide- co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment J Contr Rel. 119 41 51 10.1016/j.jconrel.2007.01.009 1:CAS:528:DC%2BD2sXksVejtLo%3D (Pubitemid 46561540)
23. MJ Copland MA Baird T Rades JL McKenzie B Becker F Reck PC Tyler NM Davies 2003 Liposomal delivery of antigen to human dendritic cells Vaccine 21 883 90 10.1016/S0264-410X(02)00536-4 1:CAS:528:DC%2BD3sXltlSgtA%3D%3D 12547598 (Pubitemid 36126422)
24. D Mishra PK Mishra V Dubey M Nahar S Dabadghao NK Jain 2008 Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen loaded modified liposomes Eur J Pharm Sci. 33 424 33 10.1016/j.ejps.2008.01.015 1:CAS:528:DC%2BD1cXktlGjs74%3D 18359615
25. P Kocbek N Obermajer M Cegnar J Kos J Kristl 2007 Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J Contr Rel. 120 18 26 10.1016/j.jconrel.2007.03.012 1:CAS:528:DC%2BD2sXmt1Gls7g%3D (Pubitemid 46874614)
26. A Dube N Singh S Sundar N Singh 2005 Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persists in in vitro and in vivo experimental models Parasitol Res. 96 216 23 10.1007/s00436-005- 1339-1 15868188 (Pubitemid 40933669)
27. PY Guru AK Agarwal UK Singhal A Singhal CM Gupta 1989 Drug targeting in Leishmania donovani infections using tuftsin bearing liposomes as drug vehicles FEBS Lett. 245 204 8 10.1016/0014-5793(89)80222-4 1:CAS:528:DyaL1MXhvF2jtrw%3D 2538359 (Pubitemid 19076232)
28. M Senthilkumar G Subramanian A Ranjitkumar M Nahar P Mishra NK Jain 2007 PEGylated Poly (Lactide-co-Glycolide) (PLGA) nanoparticulate delivery of Docetaxel: synthesis of diblock copolymers, optimization of preparation variables on formulation characteristics and in vitro release studies J Biomed Nanotech. 1 52 60
29. T Dutta NK Jain 2007 Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer Biochem Biophy Acta 1770 681 6 1:CAS:528:DC%2BD2sXit1Ggsbs%3D
30. MS Espuelas P Legrand JM Irache C Gamazo AM Orecchioni J-Ph Devissaguet P Ygartua 1997 Poly (ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity Int J Pharm. 158 19 27 10.1016/S0378-5173(97) 00194-4 1:CAS:528:DyaK2sXotVOjtLc%3D (Pubitemid 27504470)
31. J Panyam V Labhasetwar 2004 Targeting intracellular targets Cur Drug Del. 1 235 47 10.2174/1567201043334768 1:CAS:528:DC%2BD2cXkvVyrtLc%3D
32. A Budhian SJ Siegel KI Winey 2007 Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content Int J Pharm. 336 367 75 10.1016/j.ijpharm.2006.11.061 1:CAS:528:DC%2BD2sXkvFajs7g%3D 17207944 (Pubitemid 46670649)